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Abstract. In this paper, we present a regression model that predicts
perceived financial burden that a cancer patient experiences in the treatment
and management of the disease. Cancer patients do not fully understand
the burden associated with the cost of cancer, and their lack of understanding
can increase the difficulties associated with living with the disease, in
particular coping with the cost. The relationship between demographic
characteristics and financial burden were examined in order to better
understand the characteristics of a cancer patient and their burden,
while all subsets regression and machine learning algorithms were used to
determine the best predictors of financial burden. Age, BMI, household
income, and breast cancer are the strongest predictors of financial burden,
out of which breast cancer patients are most at risk to suffer from
high financial burden. Our findings indicate that certain demographic
characteristics have a larger impact on perceived financial burden than
others, making it possible to target certain demographic groups with
increased education in order to aid in the management of the disease.
1 Introduction
In the research world one of the topics that is most heavily studied is cancer.
The volume of research being conducted is closely related to the rise in incidence.
In 2018, there will be an estimated 1,735,350 new cancer cases diagnosed while
the total annual cost of cancer care in the US is estimated to reach $175 billion
by 2020, an increase of 40% from 2010 [American Society of Clinical Oncology].
According to the Medical Expenditure Panel Survey from the Agency for Healthcare
Research Quality, cancer care costs an average of $85,201 per patient in 2010-
2011, an increase of 40% from 2010 [American Society of Clinical Oncology].
Even with health insurance, cancer patients often find themselves vulnerable
to medical debt and bankruptcy. A major contributor is cancer patient’s lack
of understanding of the costs associated with cancer. Some costs are more
obvious such as the cost of chemotherapy, but there are hidden costs as well
such as transportation, job loss and travel to and from appointments which
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are often not considered. When these hidden costs are ignored, the burden of
living with cancer on a day to day basis can increase. Therefore, cancer patients
need to be well educated on the costs prior to beginning treatment. In order to
better educate cancer patients, first we need to understand the characteristics
which could make a cancer patient more susceptible to experiencing financial
burden. However, these characteristics are not well understood, and without
this understand reaching the cancer patients in need becomes a difficult task.
Prior research has shown that certain demographic populations have higher
cost associated with cancer. However, this approach to understanding financial
burden only takes into account the more obvious costs such as direct medical
costs and out of pocket expenses. It fails to capture the hidden costs which
can be taxing on patients. An efficient method of assessing hidden costs is to
measure perceived financial burden. Each cancer patient has different hidden
costs, making it difficult to accurately assess the costs. Examining perceived
burden allows for a retrospective look into how cancer patient’s financial situation
was impacted by the diagnosis, and since perception is best measured with self-
report questions, you get clear insight into how patients see the burden places
upon themselves.
Our results indicate that female participants had higher perceived financial
burden than male participants, while Caucasian participants had the least financial
burden compared to other ethnicities. Participants who received a recent checkup
were also more likely to have higher perceived financial burden, while participants
with higher household income were less likely to have higher financial burden.
The type of cancer was also important in assessing how participants view their
financial burden. Participants with breast cancer had significantly higher perceived
financial burden than participants with other forms of cancer.
These results start to illuminate the characteristics of cancer patients who
may be susceptible to high financial burden. They also show that not all cancer
patients experience financial burden equally, as some types of cancer may place
greater burden on patients than others. Therefore, the way we educate cancer
patients on the burden they experience cannot be the same for all types of
patients and for all types of cancer. A special targeted educational program may
be the solution which caters to the specific demographic groups that need the
assistance.
To better understand the problem, the paper first goes over what is cancer,
the types of cancer, and ways to treat the diagnosis. It then highlights the cost
of cancer and the impact and perceived burden. Information on the data file
used, the analysis methods, and results are subsequently presented. Finally, the
ethics associated with this type of research and the conclusion make up the final
sections of the paper.
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Cancer is a collection of hundreds of related diseases. Some of the body’s cells
begin to divide and reproduce unchecked and spread into surrounding tissues.
Cancer can be made up of trillions of these ‘rogue’ cells
2.2 Types of Cancer
There are many different types of cancer characterized by abnormal cell growth.
They are generally identified by the body area they target.
A cancer that forms in the cells of the breasts is known as breast cancer.
According to the American Cancer Society, an estimated 22 percent of people
live at least five years after being diagnosed with stage 4 breast cancer. Many
factors can affect the chances of long-term survival of cancer patients.
A man’s prostate produces the seminal fluid that nourishes and transports
sperm. Symptoms of cancer in the prostate include difficulty with urination,
but in some cases no symptoms present in patients. Approximately 90% of all
prostate cancers are detected in the local and regional stages, so the cure rate
is very high: Nearly 100% of men diagnosed and treated at this stage will be
disease-free after five years. However, prostate cancer is still a deadly disease
if not diagnosed early enough. A type of skin cancer begins in the basal cells.
Basal cells produce new skin cells as old ones die. Limiting sun exposure and
protecting the skin using sunscreens can help prevent these cells from becoming
cancerous. This cancer typically appears as a white waxy lump or a brown
scaly patch on sun-exposed areas, such as the face and neck. Melanoma occurs
when the pigment-producing cells that give color to the skin become cancerous.
Symptoms might include a new, unusual growth or a change in an existing mole.
Melanomas can occur anywhere on the body. Treatment may involve surgery,
radiation, medication, or in some cases chemotherapy. A cancer can also form
in the colon or rectum, which is located at the digestive tract’s lower end. Early
cases can begin as noncancerous polyps. These often have no symptoms but
can be detected by screening. Colorectal cancer symptoms depend on the size
and location of the cancer. Some common symptoms include changes in bowel
habits, changes in stool consistency, blood in the stool, and abdominal pain.
Treatement for colorectal cancer alsodepends on the size, location, andthe extent
of malignancy. Common treatments include surgical removal, chemotherapy, and
radiation therapy.
Lung cancer most often occurs in people who smoke. Two major types of
lung cancer are non-small cell lung cancer and small cell lung cancer. Causes
of lung cancer include smoking, secondhand smoke, exposure to certain toxins,
and family history. Symptoms include cough (often with blood), chest pain,
wheezing, and weight loss. These symptoms often don’t appear until the cancer
is advanced. Leukemia is cancer of blood-forming tissues, including bone marrow.
Many types exist such as acute lymphoblastic leukemia, acute myeloid leukemia,
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and chronic lymphocytic leukemia. Many patients with slow-growing types of
leukemias don’t show any symptoms. Rapidly growing types of leukemia may
cause symptoms that include fatigue, weight loss, frequent infections, and easy
bleeding or bruising. The lymphatic system is the body’s disease-fighting network.
It includes the lymph nodes, spleen, thymus gland, and bone marrow. The main
types of cancer in the lymphatic system are Hodgkin’s lymphoma and non-
Hodgkin’s lymphoma. Symptoms of lymphoma include enlarged lymph nodes,
fatigue, and weight loss.
2.3 Types of Cancer Treatment
There are many types of cancer treatment. Some people will have only one
treatment whereas some will be combinations of treatments such as surgery and
radiations.
Surgery is a procedure in which a surgeon removes cancer from the body.
During surgery, the tumor and surrounding tissue are removed. Surgery is the
oldest type of cancer therapy and remains an effective treatment for many types
of cancer today as long as the cancer has not spread too much to other parts of
the body. If the cancer has spread, surgery might not be the best treatment and
it may be better to have a treatment that reaches all parts of your body, such
as chemotherapy, biological therapy or hormone therapy.
Radiation therapy may be used alone or in combination with surgery,
chemotherapy, or both. Radiation therapy may also be given with palliative
intent. Palliative treatments are not intended to cure. Instead, they relieve
symptoms and reduce the pain and suffering caused by cancer. More than half
of cancer patients receive some type of radiation therapy. For some cancers,
radiation therapy alone is an effective treatment. Other types of cancer respond
best to combination of the treatment methods. This may include radiation
therapy plus surgery, chemotherapy, or immunotherapy. Chemotherapy (chemo)
usually refers to the use of medicines or drugs to treat cancer. The thought of
chemotherapy frightens most patients. But knowing what chemotherapy is, how
it works, and what to expect can often help calm the fears. It can also give
a better sense of control over cancer treatment. Immunotherapy is a type of
treatment that utilizes the human body’s own immune system to fight cancer.
This can be done in two ways. The first involves stimulating the immune system
to work harder or smarter to attack cancer cells while the second method invoves
giving the immune system extra components, such as man-made immune system
proteins. A stem cell transplant is also a suitable treatment for some types
of cancer. For example, it is effective against leukemia, multiple myeloma and
some types of lymphomas. A part of bones called “bone marrow” makes blood
cells. Marrow is the soft, spongy tissue inside bones. It contains cells called
“hematopoietic” stem cells. These cells can turn into several other types of cells.
They can grow into more bone marrow cells. Or they can grow into any other
type of blood cell. Certain cancers and other diseases keep hematopoietic stem
cells from developing normally. If they are not normal, neither are the blood
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cells that they make. A stem cell transplant gives you new stem cells which can
make new, healthy blood cells.
2.4 Cyles of Cancer Treatment
A series of cycles of treatment is called a course. A treatment course often takes
between 3 to 6 months but it can be longer than that. During that time, a patient
can probably have between 4 to 8 types of treatment. For example, a person can
have both surgery and chemotherapy.
Depending on the combination of treatments, an individual treatment may
last from a few months to a few years. Treatment cycles might be weekly or
might take 2, 3 or 4 weeks, depending on the drugs and the treatment plan.
Some treatment cycles are quite complicated which is defined by the phase of
the cancer cells.
3 Cost of Cancer
A cancer diagnosis can be expensive and a major source of stress and anxiety.
Sometimes, the enormous costs keep people away from completing cancer treatment
which increases health risks. Some of the factors that contribute to cost of cancer
care are explained below.
The first cost is related to the doctor appointments. This includes payments
for care you receive at each doctor visit. Typically, your insurance provider
requires you to pay a certain amount from your own pocket, also referred to
as a co-payment or co-pay. The co-pay amount is specified by the insurance
provider. This fee needs to be paid for each appointment.
You may also have to pay for tests done during your appointment. For
example, laboratory tests, such as blood or urine tests. These lab charges generally
depend on the difficulty or sophistication of the tests involved.
Another major factor is the cost related to the actual treatment. This includes
payments for care you receive during your cancer treatment. For example, each
radiation therapy session or chemotherapy infusion.
Medications are also an important part of cancer treatment. Cost of medications
include payments for drugs prescribed during your treatment period. For example,
chemotherapy or drugs to help manage side effects.
Mobilization costs are sometimes ignored by patients but they should always
be considered. They depend on where you are receiving treatment and how you
get there. These include but are not limited to the gas, toll, parking fees and
taxi, bus, train or airplane fares.
Some people receive treatment far from home, out of choice or necessity. In
this case, you may need to pay for lodging. These include costs of household
upkeep and family care during cancer treatment. For example, a cancer patient
may require childcare or elder care. They also need help with household chores
such as cleaning and cooking. Cancer can mentally impact the patients a lot
so they also need counselling to help them through this difficult phase of life.
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Depending on the severity of the cancer, the patients also need caregiving such
as help with cooking, nursing and even simply moving around to get groceries
or get to doctor appointments on time.
There are also employment-related, legal, and financial costs. These include
costs of professional help with employment, legal, or financial issues. Professionals
may help with coping with the loss of wages and consistent income, learning
about employment rights under the law, preparing and filing for taxes to account
for medical expenses and writing a will.
4 Cost Impact
Cancer is one of the leading causes of death and disease in the U.S. The American
Cancer Society (ACS) estimates that roughly 1.7 million new cases of cancer will
be diagnosed in the U.S. in 2017 and more than 15 million Americans living today
have a cancer history.
In 2014 cancer patients paid nearly 4 billion out-of-pocket for cancer treatments.
Cancer also represents a significant proportion of total U.S. health care spending.
With more than 200 different types of cancer, there is no one size fits all
cancer treatment, but there are several consistent factors that contribute to
patients’ overall costs for their care.
4.1 Cost impact and perceived burden
Cancer treatment can be very expensive and lengthy which can take a toll on the
impacted individuals. For example, Individuals even with insurance, can be hard
hit financially and psychologically by cancer treatment. The costs of treatments
including surgery and expensive drugs, as well as non-medical supportive needs,
such as child care, can be crippling. These type of financial burden is linked
to psychological problems such as depression, mood swings, more worry about
cancer recurrence, and lower quality of life. Furthermore, this may lead to
foregoing or delaying care or medications which is in turn connected to health-
related outcomes and importantly mortality.
4.2 Family dynamics
In families with a person diagnosed with cancer, financial issues emerge as
a significant concern at a time when these families were already consumed
with other challenges. This economic burden can have long-term effects on the
financial security, quality of life, and future well-being of the entire family.
4.3 Long term side effects
The impact of having cancer does not always end when treatment finishes.
The long-term consequences of cancer and its treatment include both physical
and mental effects, such as chronic fatigue, sexual difficulties, mental health
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Fig. 1. Direct vs Indirect Cost
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problems, pain, urinary and gastrointestinal problems, and lymphoedema (persistent
tissue swelling caused by fluid retention). Many of these problems can persist
for at least 10 years after treatment and can be significantly worse than those
experienced by people without cancer. Certain treatments for cancer also increase
the risk of other serious long-term conditions such as heart disease, osteoporosis
or a second cancer.
4.4 Short term side effects
In short term some people living with and beyond cancer experience chronic
fatigue which may lead to inability to perform their jobs because they cannot
work consistently or efficiently. Some consequences of cancer and its treatment
can be reduced with simple interventions, while more complex issues require
specialist services.
4.5 Physical impacts
Some of the examples of the physical impacts include the following: Functional
health impairment, such as the inability to undertake labor-intensive tasks,
limitations in mobility due to the loss of a limb. Physical health impacts includes
coping with pain, nausea, fatigue, reduced hearing and/or vision. Mental health
impacts such as lack of sleep, stress, anxiety, depression, personality changes from
brain surgery. Cognitive health impairments such as the impact on memory, IQ,
and the inability to remain focused.
5 Data
The Health Information National Trends Survey (HINTS) data collection program
was developed by the Health Communication and Informatics Research Branch
(HCIRB) of the Division of Cancer Control and Population Sciences (DCCPS)
as an after effect of the National Cancer Institute’s Extraordinary Opportunity
in Cancer Communications. This program was designed to help understand and
learn more about communication and informatics research that takes place at
the NCI. The HINTS data collection program is a national survey which has
been administered every other year starting from 2003 and it was created to
monitor changes in the rapidly evolving field of health communication. The data
was collected in accordance to the privacy act Section 411.285a, 42 USC, and
paperwork reduction act of 1995. The information was gathered as an interview
process in which participants were asked to complete a set of questions within a
duration of 20 to 30 minutes. This data provided insights on changing patterns,
needs, information opportunities in health, communications trends, how cancer
risks are perceived and what the best practices are. It also assesses cancer
information access, usage and provides researchers to test new theories in health
communication.
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Researchers are using this data to get insights on how adults 18 years and
older use different communication methodologies, including but not limited to
the Internet, to obtain vital health information for themselves and their family
members. Program planners are using this same data to overcome communication
barriers across populations by developing effective communication strategies and
finally social scientists are using the data to narrow their theories of health
communication in the age of technology and to offer new and better recommendations
for reducing the burden of cancer throughout the population.
Returned HINTS surveys were reviewed to ensure they were eligible for
inclusion in the final dataset, surveys were reviewed for completion and duplication.
A survey questionnaire was considered to be complete if at least 80% of Sections
A and B were answered, and it’s considered to be partially complete if 50% to
79% of the questions were answered in Sections A and B. Handling of duplicate
survey were put to the follwing removal process: If the same respondent returned
multiple questionnaires, the first questionnaire was considered complete. If the
same respondent returned multiple questionnaires on the same day, the first
questionnaire to complete the editing process was considered complete. If a
return date was unavailable for questionnaires from the same respondent, the
questionnaire with fewer substantive questions omitted was was considered complete.
If different respondents returned a questionnaire and the ages of household
members listed in the roster were in agreement, the questionnaire that complied
with the next birthday rule was considered complete.
Every questionnaire that was considered completed, received a full-sample
weight. The full-sample weight is used to calculate population and subpopulation
estimates, replicate weights were also used to compute standard errors for these
estimates, the use of sampling weights is done to ensure valid inferences from the
responding sample to the population, correcting for nonresponse and noncoverage
biases. Also the replicate weights were calculated using the ”delete one” jackknife
replication method. For the purpose of this study, we will be ignoring the partially
completed survey questionnaire and focusing on the completed ones as shown in
the graph.
To avoid bias for attrition from noncontacts, screener nonresponse, weights
were assigned to account for all of the stages of selection. These weights were
designed to provide approximately unbiased estimators of population. Replicate
weights were also provided to allow for consistent variance estimation. The
jackknife replication method was used, with R = 50 replicate weights for each
survey year for all of the biennial HINTS surveys. A carefully selected portion
of the original sample, roughly 1/50 of the original sample was deleted and the
remaining sample was reweighed as if the complement set was the full sample.
For the purposes of our study, 3 of the HINTS datasets were merged to create
one master data file (see Table 1 for more information on the individual data
files).
After the datasets were merged, participants who indicated they had never
received a diagnosis of cancer were removed from the data file. The final data
file consisted of information from 1,595 patients who had received a diagnosis of
9
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Fig. 2. HINTS Data Set
Table 1. Health Information National Trends Survey Data set
HINTS Cycles Start End N
5 1 January 25, 2017 May 5, 2017 3,191
4 4 August 19, 2014 November 17, 2014 3,529
4 2 October 2012 January 2013 3,582
cancer and 41 different variables. Out of which only 1,359 patients responded to
”CancerHurtFinances” variable with valid answers ranging as such (1=”Not at
all”, 2=”A little”, 3=”Some” and 4=”A lot”). Some of the variables that were
examined included health variables like smoking status, general health indices,
and most recent checkup. General demographic variables such as age, gender,
ethnicity, etc. were also examined. Finally, different types of cancer diagnosis
were examined. Table 2 displays the full list of variables that were used in this
study.
6 Analysis Methods
All analyses were conducted in SAS and Python. Prior to any model being
created, bivariate relationships were tested between perceived financial burden
and each of the variables in the data file. Spearman’s correlations were conducted
to examine the relationship between rank order variables and perceived financial
burden. Spearman’s coefficient is a statistical measure of the strength of a
relationship between two ordinal variables, with coefficient values of .00 - .39
indicating a weak relationship, .40 - .59 indicating a moderate relationship,
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and .60 and higher indicating a strong relationship. Independent samples t-
tests were also conducted to examine the relationship between dichotomous
variables and perceived financial burden, while one-way analysis of variance
(ANOVA) was conducted to examine the relationship between variables with
more than two levels and perceived financial burden. The independent samples
t-Test compared the means of two independent groups in order to determine
whether the means from the associated population are significantly different,
and the one-way ANOVA determines whether the means from more than two
independent groups are significantly different.
To create the best model, machine learning algorithms were utilized. Specifically
3 models were tested and compared to each other: Gaussian na¨ıve bayes, decision
tree classifier, and random forest classifier. Machine learning algorithms allow
for more accurate results and provides researchers a better chance of identifying
important predictors. Therefore, we decided to first run these 3 models to determine
which of the three provide the most accurate model. Standard machine learning
procedures such as cross validation were used. Of the 1,595 cancer patients we
had, 70% of the data was set aside for the training data, 15% for the testing
data, and 15% for the final validation data. Testing data is set aside as we want
to see how the new model we fit on the training data compared to the original
model. Once we have identified the best model, we will have the model identify
which are the most important predictors of perceived financial burden.
All subsets regression will then be utilized in order to determine which of the
other variables not deemed as most important significant predictors of perceived
financial burden are. In statistical modeling, regression analysis is a process for
estimating the relationships between a set of independent or predictor variables
and a single continuous dependent or outcome variable. Regression allows us to
understand how the values of the dependent variable changes when any of the
independent variables are varied. All subsets regression is a particularly efficient
technique where there is no natural ordering to the explanatory variables.
When conducting all subsets regression, the first step is to identify which
combination of predictor variables are best at explaining the outcome variable.
In order to do this, a model fit indices must be selected. Four common indices are
utilized, Adjusted R-Square, R-Square, AIC, and SSE. For the purposes of this
study, adjusted R-square was used to determine the best model. The adjusted
R-square tells you the amount of variance explained in the outcome variable
by the predictor variables. Once the best model was identified, a multiple linear
regression was conducted to determine which of the predictor variables identified
in the prior step a significant predictor of perceived financial burden.
7 Results
Preliminary analyses aimed at identifying relationships between demographic
characteristics and perceived financial burden revealed several significant findings.
Female participants had significantly higher perceived financial burden than male
participants as shown in Figure. 2. This could be attributed to the difference in
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wages between males and females, as studies have indicated that women working
full time in the US are typically paid just 80% of what men were paid [1].
Our results also indicated that Caucasian participants had the least financial
burden compared to other ethnicities, while American Indians/Alaskan natives
had the highest financial burden (also shown in Figure X below). This could
also be explained by earning gap between Caucasians and people from different
ethnicities. White families earn nearly 10 times more than African American
families [2], and the gap is even larger when considering other minorities. Finally,
preliminary findings also identified differences in participant’s financial burden
and the type of cancer they had. Participants with breast cancer had significantly
higher perceived financial burden than participants with other forms of cancer.
In 2010, the cost of treating breast cancer was approximately $16.5 billion, higher
than any other type of cancer [3]. This burden placed on breast cancer patients
could significantly impact the perceived burden as well.
The main regression model indicated several additional demographic predictors
of perceived financial burden. Participants who received a recent checkup were
more likely to have higher perceived financial burden. Conceptually this makes
sense as patients are charged after every visit, therefore the financial burden
they experience would naturally be higher after a checkup. General health was
also significantly related to financial burden, healthier participants were more
likely to have higher perceived financial burden. This finding is contrary to the
conventional belief that healthier individuals are less likely to visit the doctor’s
office, thereby bringing down their financial burden. One possible explanation for
this finding is that the relationship between psychosocial stressors and disease
is affected by the nature, number, and persistence of the stressors [4]. Healthier
patients may feel high levels of stress, which in turn impacts their perceived
financial burden.
Age was also a significant demographic predictor, younger people were more
likely to have higher perceived financial burden. In general older participants are
financially better off than younger participants as they have been working for
a longer period of time, so this findings is in line with the belief that younger
participants have fewer financial resources than older participants. Finally, participants
with lower household income were more likely to have higher perceived financial
burden. This finding also ties into the fact that participants who have more
wealth and financial resources can cope with financial burden better than participants
with low income.
In addition to demographic predictors, the regression model also included
different types of cancer to determine if the type of cancer is significantly related
to perceived financial burden. Our results revealed that the type of cancer does
matter, as not all types of cancer were significantly related to financial burden.
Bone, cervical, colon, pancreatic, renal, and stomach cancers were not significant
predictors, indicating that patients with these ailments did not show significant
differences in their financial burden compared to patients with other types of
cancer. Colon and pancreatic cancer are two of the deadliest forms of cancer,
and even an early diagnosis does not aid in stopping the spread The 10 Deadliest
12
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Cancers and Why There’s No Cure. Therefore, since many patients don’t live
for a long time with the ailment there cost will be lower, and so our model was
unable to detect a significant relationship with financial burden.
There were several types of cancer that were related to perceived financial
burden. Bladder, breast, endometrial, head and neck, hodgkins, leukemia, lung,
non-hodgkin, pharyngeal, prostate, and rectal cancers were all significant predictors.
Breast cancer as mentioned earlier is one of the most expensive forms of cancer,
so you would expect to see a relationship with perceived financial burden. Breast
cancer is also in the top 5 when it comes to survival rates, with only about 10% of
patients dying from the disease within 5 years of receiving the diagnosis Cancer
Survival Rate Statistics by Type of Cancer. Prostate, (.8%), bladder (22.1%),
and rectal (33.5%) are also in the top 10 when analyzing the survival rate. This
relationship with survival rate could help explain why these types of cancers
were significantly related to financial burden, as the longer a patient survives
with these cancers the higher the cost, which in turn increases the financial
burden.
8 Ethics
As the cost of research increases, more researchers are turning to surveys for
their data collection purposes as they are relatively inexpensive [5]. The dataset
we used also came from a survey which was used to describe the characteristics
of a larger population but made it affordable for the researchers to access the
population. However, when doing survey research there are several ethical components
that must be considered. First and foremost, the survey needs to be taken on
a voluntary basis by participants [6]. The people who receive this survey need
to be told that participation in the survey is completely voluntary. In order
to make taking the survey appealing to participants, it is ethical to incentivize
participants with monetary values as long as they also understand what the
reward will be for completing the survey. Participants also need be informed
about the risks, benefits, and facts before they make the decision to participate.
Falsely leading participants to take something that could lead to emotional
damage takes away participants right to choose whether or not this survey is right
for them. Also if you know your survey could be detrimental to participants, as a
researcher you should strive to word the questions in such a way that it minimized
potential harm to participants. As researchers who use surveys to understand the
behavior or opinions of our participants we should attempt to avoid introducing
bias into the questions that lead participants to answer a certain way. Not only
do you not want participants to be influenced in how they respond to questions,
you also do not want the questions themselves or the ordering of the questions to
impact how participants respond. Finally, the most important aspect of survey
research is to maintain the privacy and confidentiality of survey participants.
In most cases surveys won’t ask for any information that can identify you, and
if they do those questions will be asked on a separate survey so identifying
information cannot be linked back to your responses. The data stored from the
13
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Fig. 3. Data visualization
surveys should also be kept in a secure location where information cannot be
hacked into or leaked. Participants who take the survey are taking it with the
faith that the data or any personal information won’t be used in an inappropriate
fashion and allowing someone to access the data who shouldn’t may allow for
identity theft etc. The HINTS survey met the requirements for all of the above
points, and since the researchers have conducted this survey multiple times the
process put into place ensures that the data is secure, participants take the
survey of their own free will, consent is received prior to any questions being
shown, and the questions are worded to minimize harm to participants.
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9 Conclusion
While tackling cancer, most cancer patients, might overlook cost related burdens
associated with cancer, and their lack of oversight on this burden can increase
the difficulties associated with living with the disease. Our model guides patients
regarding perceived financial burden due to cancer and minimize difficulties
living with the disease. Our findings also indicate that certain demographic
characteristics have a larger impact on perceived financial burden. Age, BMI,
Time To Moderate Exercise, Education, household income, and breast cancer
are the strongest predictors of perceived financial burden. In short cancer is a
journey that financially impacts you for the rest of your life.
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Table 2. Cookbook
Variable Name Variable Label
MailHHAdults 2. Including yourself, how many people age 18 or older live in this
household?.
MostRecentCheckup C3. About how long has it been since you last visited a doctor for a
routine checkup? A routine checkup is a general physical exam, not an
exam for a specific injury, illness, or condition.
HealthInsurance C2. Do you have any kind of health care coverage, including health
insurance, prepaid plans such as HMOs or government plans such as
Medicare?
GeneralHealth F1. (E1.) In general, would you say your health is...
TimesModerateExercise H1. (F5.) In a typical week, how many days do you do any physical
activity of at least moderate intensity?
smokeStat Smoking Status
EverHadCancer M1. (J1.) Have you ever been diagnosed as having cancer?
TimeSinceDX How long ago were you diagnosed with cancer?
Age O1. (L1.) What is your age?
OccupationStatus O2. (L2.) What is your current occupational status?
MaritalStatus O5. (L5.) What is your marital status?
Education O6. (L6.) What is the highest grade or level of schooling you completed?
BornInUSA O7. (L7.) Were you born in the United States?
BMI Body Mass Index (Weight*703)/(Height in inches**2)
RaceEthn Race/Ethnicity.
RentOrOwn O15. (L15.) Do you currently rent or own your home?
HHInc What is your combined annual household income?
GenderC K1. (H1.) Are you male or female?
CancerHurtFinances M10. Looking back, since the time you were first diagnosed with cancer,
how much, if at all, has cancer and its treatment hurt your financial
situation?
CaBladder M2. (J2.) What type of cancer did you have? Bladder cancer
CaBone M2. (J2.) What type of cancer did you have? Bone cancer
CaBreast M2. (J2.) What type of cancer did you have? Breast cancer
CaCervical M2. (J2.) What type of cancer did you have? Cervical cancer (cancer
of the cervix)
CaColon M2. (J2.) What type of cancer did you have? Colon cancer
CaEndometrial M2. (J2.) What type of cancer did you have? Endometrial cancer
(cancer of the uterus)
CaHeadNeck M2. (J2.) What type of cancer did you have? Head and neck cancer
CaHodgkins M2. (J2.) What type of cancer did you have? Hodgkin’s lymphoma
CaLeukemia M2. (J2.) What type of cancer did you have? Leukemia/Blood cancer
CaLiver M2. (J2.) What type of cancer did you have? Liver cancer
CaLung M2. (J2.) What type of cancer did you have? Lung cancer
CaMelanoma M2. (J2.) What type of cancer did you have? Melanoma
CaNonHodgkin M2. (J2.) What type of cancer did you have? Non-Hodgkin lymphoma
CaOral M2. (J2.) What type of cancer did you have? Oral cancer
CaOvarian M2. (J2.) What type of cancer did you have? Ovarian cancer
CaPancreatic M2. (J2.) What type of cancer did you have? Pancreatic cancer
CaPharyngeal M2. (J2.) What type of cancer did you have? Pharyngeal (throat)
cancer
CaProstate M2. (J2.) What type of cancer did you have? Prostate cancer
CaRectal M2. (J2.) What type of cancer did you have? Rectal cancer
CaRenal M2. (J2.) What type of cancer did you have? Renal (kidney) cancer
CaSkin M2. (J2.) What type of cancer did you have? Skin cancer, non-
melanoma
CaStomach M2. (J2.) What type of cancer did you have? Stomach cancer
16







t Value Pr >|t|
Intercept 13.89 3.66 3.80 0.00
MailHHAdults 0.05 0.05 1.09 0.27
MostRecentCheckup 0.06 0.05 1.29 0.20
GeneralHealth 0.11 0.04 2.62 0.01
TimesModerateExercise -0.02 0.02 -1.23 0.22
TimeSinceDX -0.04 0.04 -1.07 0.28
Age -0.02 0.00 -5.71 <.0001
RaceEthn 0.10 0.04 2.71 0.01
HHInc -0.12 0.03 -4.05 <.0001
CaBladder -0.78 0.28 -2.78 0.01
CaBone 1.26 0.91 1.38 0.17
CaBreast -0.67 0.10 -6.54 <.0001
CaCervical 0.22 0.14 1.60 0.11
CaColon -0.24 0.16 -1.48 0.14
CaEndometrial -0.52 0.20 -2.53 0.01
CaHeadNeck -0.56 0.27 -2.08 0.04
CaHodgkins -0.65 0.31 -2.07 0.04
CaLeukemia -0.52 0.27 -1.95 0.05
CaLung -0.74 0.31 -2.37 0.02
CaNonHodgkin -0.79 0.24 -3.29 0.00
CaPancreatic 1.12 0.91 1.23 0.22
CaPharyngeal -0.97 0.46 -2.10 0.04
CaProstate -0.32 0.12 -2.71 0.01
CaRectal -0.51 0.29 -1.72 0.09
CaRenal -0.31 0.23 -1.33 0.18
CaStomach -0.69 0.46 -1.51 0.13
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